SORCS1 alters amyloid precursor protein processing and variants may increase Alzheimer's disease risk

C Reitz, S Tokuhiro, LN Clark, C Conrad… - Annals of …, 2011 - Wiley Online Library
C Reitz, S Tokuhiro, LN Clark, C Conrad, JP Vonsattel, LN Hazrati, A Palotás, R Lantigua…
Annals of neurology, 2011Wiley Online Library
Objective: Sorting mechanisms that cause the amyloid precursor protein (APP) and the β‐
secretases and γ‐secretases to colocalize in the same compartment play an important role
in the regulation of Aβ production in Alzheimer's disease (AD). We and others have reported
that genetic variants in the Sortilin‐related receptor (SORL1) increased the risk of AD, that
SORL1 is involved in trafficking of APP, and that underexpression of SORL1 leads to
overproduction of Aβ. Here we explored the role of one of its homologs, the sortilin‐related …
Objective
Sorting mechanisms that cause the amyloid precursor protein (APP) and the β‐secretases and γ‐secretases to colocalize in the same compartment play an important role in the regulation of Aβ production in Alzheimer's disease (AD). We and others have reported that genetic variants in the Sortilin‐related receptor (SORL1) increased the risk of AD, that SORL1 is involved in trafficking of APP, and that underexpression of SORL1 leads to overproduction of Aβ. Here we explored the role of one of its homologs, the sortilin‐related VPS10 domain containing receptor 1 (SORCS1), in AD.
Methods
We analyzed the genetic associations between AD and 16 SORCS1–single nucleotide polymorphisms (SNPs) in 6 independent data sets (2,809 cases and 3,482 controls). In addition, we compared SorCS1 expression levels of affected and unaffected brain regions in AD and control brains in microarray gene expression and real‐time polymerase chain reaction (RT‐PCR) sets, explored the effects of significant SORCS1‐SNPs on SorCS1 brain expression levels, and explored the effect of suppression and overexpression of the common SorCS1 isoforms on APP processing and Aβ generation.
Results
Inherited variants in SORCS1 were associated with AD in all datasets (0.001 < p < 0.049). In addition, SorCS1 influenced APP processing. While overexpression of SorCS1 reduced γ‐secretase activity and Aβ levels, the suppression of SorCS1 increased γ‐secretase processing of APP and the levels of Aβ.
Interpretations
These data suggest that inherited or acquired changes in SORCS1 expression or function may play a role in the pathogenesis of AD. Ann Neurol 2011;69:47–64.
Wiley Online Library